Aurobindo Pharma | ARBP - Cash And Equivalent

Stock Price
1,409.85
Daily Change
-11.45 -0.81%
Monthly
8.18%
Yearly
16.55%
Q2 Forecast
1,382.70

Aurobindo Pharma reported INR88.91B in Cash and Equivalent for its fiscal quarter ending in September of 2025.





Cash And Equivalent Change Date
Cipla INR 7.96B 39.9M Sep/2025
Divis Laboratories Ltd INR 4.15B 31.87B Mar/2025
Dr.Reddys Laboratories INR 18.66B 8.75B Dec/2025
Hindustan Unilever INR 44.42B 16.29B Sep/2025
Sun Pharmaceuticals INR 113.32B 33.19B Mar/2025
UPL INR 41.52B 53.85B Sep/2025